Leo Cancer Care secures £18.5m in Series B funding led by Pureland Global Venture to advance upright radiotherapy solutions.
Pureland Global Venture led the Series B financing round to support the commercialisation of upright treatment technology.
Leo Cancer Care develops upright radiotherapy solutions that improve clinical effectiveness and patient experience. The firm builds gantryless systems designed to make particle and proton therapy more accessible.
Leo Cancer Care has secured £18.5m in a Series B funding round led by Pureland Global Venture. The financing saw participation from international institutional investors and industry partners, including Yu Galaxy, WARF, Alumni Ventures, Junson Capital, Serra Ventures, CHC, Cosylab, Toret Devices, and Radiation Business Solutions. The capital will be used to commercialise upright treatment technology, expand international teams, and advance photon technology development.
The company designs gantryless radiotherapy equipment that rotates the patient rather than the machine, offering a smaller footprint and simpler installation than traditional devices. The fresh funds will enable the business to scale its operations across the US, Europe, and Singapore, as well as pursue mobile treatment solutions.
From the founder
"We founded Leo Cancer Care to revolutionize the Radiation Therapy space and achieving those sorts of goals only happens when you have incredible partners. Pureland Ventures has been amazing on this journey so far, so it is fantastic to have them lead this Series B financing round. It’s really exciting to see such a great balance of institutional and industry investments, it shows that the industry really shares in our vision for driving change."
Stephen Towe
CEO at Leo Cancer Care
Investor perspective
"It is with the greatest pleasure that we announce our support of Leo Cancer Care as part of their recent fundraising process. We are a strong believer in the company and believe that it will change the cancer treatment pathway forever."
Mark Wang
Managing Partner, Pureland Global Venture
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Mark Wang
Pureland Global Venture
Yu Galaxy
WARF
Alumni Ventures
Junson Capital
Serra Ventures
CHC
Cosylab
Toret Devices
Radiation Business Solutions
About the company
Leo Cancer Care
Leo Cancer Care builds upright radiotherapy systems to improve cancer treatment.